Oxford Immunotec Global PLC OXFD
$ 21.99
0.0%
Oxford Immunotec Global PLC Financial Ratios 2011-2024 | OXFD
Annual Financial Ratios Oxford Immunotec Global PLC
2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|
P/E |
- | -232.5 | 3.1 | -8.5 | -13.2 | -10.3 | -9.2 | -9.1 | - | - |
P/S |
- | 5.7 | 6.2 | 2.7 | 3.4 | 4.0 | 4.1 | 2.0 | - | - |
EV/EBITDA |
- | -73.4 | -11.0 | -8.9 | -11.9 | -7.7 | -7.7 | -0.5 | - | - |
PEG |
- | 2.29 | 0.01 | 0.22 | -1.23 | -0.83 | -0.21 | 0.35 | - | - |
P/B |
- | 2.0 | 1.7 | 3.2 | 4.0 | 2.7 | 3.4 | 1.0 | - | - |
P/CF |
- | -47.7 | -16.2 | -32.3 | -12.1 | -12.6 | -8.4 | -10.3 | - | - |
ROE % |
- | -0.85 | 56.44 | -37.53 | -30.63 | -26.41 | -36.59 | -10.73 | - | - |
ROA % |
- | -0.77 | 52.03 | -22.80 | -18.02 | -22.28 | -30.03 | -9.34 | - | - |
ROCE % |
- | -2.26 | -8.24 | -23.59 | -24.09 | -25.62 | -35.10 | -9.01 | - | - |
DSO |
- | 90.8 | 83.4 | 60.1 | 56.2 | 41.0 | 50.3 | 44.7 | - | - |
DIO |
- | 210.0 | 168.5 | 79.2 | 68.8 | 87.7 | 97.7 | 106.9 | - | - |
DPO |
- | 45.8 | 60.8 | 53.4 | 29.6 | 46.9 | 36.0 | 45.3 | - | - |
All numbers in USD currency